Oncology

Serum biomarkers in lung cancer care: updates from Dr Anand Sachithanadan

Serum biomarkers in lung cancer diagnostics: updates from Dr Anand Sachithanadan

What is the role of serum biomarkers in lung cancer care and how is it changing? Dr Anand Sachithanadan, a consultant cardiothoracic surgeon with appointments at Sunway Medical and Subang Jaya Medical Centre Malaysia, provides key updates in this recent webinar hosted by Roche Diagnostics Asia Pacific. “There’s been a growing interest over the last […]

Serum biomarkers in lung cancer care: updates from Dr Anand Sachithanadan Read More »

Lung cancer diagnostics in the COVID-19 era: insights from Dr James Ho

Lung cancer diagnostics in the COVID-19 era: insights from Dr James Ho

In a recent webinar hosted by Roche Diagnostics Asia Pacific, Dr James Ho, a Clinical Associate Professor in the Department of Medicine at the University of Hong Kong, shared insights on the current state of lung cancer diagnostics and how COVID-19 is impacting patient care.  The webinar begins with an overview of the key diagnostic tools

Lung cancer diagnostics in the COVID-19 era: insights from Dr James Ho Read More »

China viewpoint: Prof Hao Xiaoke on cancer diagnostics, precision oncology and the smart lab

ProfHaothumbnail

To understand how the China’s medical community is addressing the country’s growing cancer challenges, Roche Diagnostics recently spoke with Prof Hao Xiaoke, Chief Scientist at Greater Xi’An Area Medical Diagnostic Lab Center. Prof Hao argues that the intelligent use of cancer diagnostics, which facilitate early screening and preventative care, will be essential for addressing the government’s

China viewpoint: Prof Hao Xiaoke on cancer diagnostics, precision oncology and the smart lab Read More »

Time to review the gold standard for cervical cancer screening

Time_to_review

More than 5,000 women in Thailand die every year from cervical cancer [1], according to the 2019 report from the HPV Information Centre. 70% of these cancers are caused by just two human papillomavirus (HPV) strains: HPV16 and HPV18. Both of these strains are now vaccine-preventable, but the HPV Information Centre estimates that it will take decades

Time to review the gold standard for cervical cancer screening Read More »

Improving pre-analytical processes in tissue diagnostics

Improving pre-analytical processes in tissue diagnostics

Pre-analytical preparation is the first step in the specimen journey for tissue diagnostics. It consists of  tissue collection, fixation, grossing of specimen, tissue processing, embedding and microtomy. It plays an important role in the success of tissue staining and pathology reporting, but many clinical labs struggle with this process. The webinar below explains how to optimise

Improving pre-analytical processes in tissue diagnostics Read More »

How to implement HPV DNA testing as a primary screening tool?

How to implement HPV DNA testing as a primary screening tool?

HPV DNA testing is shown to be significantly more effective compared to pap smear/cytology for cervical cancer screening. In this webinar, you will learn how to implement HPV DNA testing as a primary screening tool for cervical cancer. How to address multidisciplinary challenges during the transition phase from pap smear/cytology to HPV DNA testing? What are the considerations

How to implement HPV DNA testing as a primary screening tool? Read More »

ctDNA provides new confidence in fight against China’s deadliest cancer

ctDNA provides new confidence in China's lung cancer diagnostics

Lung cancer is the most common cancer in China [1] and the most deadly. Unlike in many Western countries, the number of lung cancer diagnoses is also continuing to rise. By harnessing ctDNA technology, we have an opportunity to significantly improve patient care and outcomes. Traditionally to confirm a cancer diagnosis, a suspected cancerous tumour is biopsied and

ctDNA provides new confidence in fight against China’s deadliest cancer Read More »

Scroll to Top